M Berger

786 total citations · 1 hit paper
12 papers, 637 citations indexed

About

M Berger is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, M Berger has authored 12 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 3 papers in Health, Toxicology and Mutagenesis. Recurrent topics in M Berger's work include Asthma and respiratory diseases (4 papers), Air Quality and Health Impacts (3 papers) and Respiratory and Cough-Related Research (2 papers). M Berger is often cited by papers focused on Asthma and respiratory diseases (4 papers), Air Quality and Health Impacts (3 papers) and Respiratory and Cough-Related Research (2 papers). M Berger collaborates with scholars based in Netherlands, United States and Germany. M Berger's co-authors include Michael W. Konstan, Kathleen A. Hilliard, Ivo N. van Schaik, M. Vermeulen, Y. B. W. E. M. Roos, Peter J. Sterk, J.H.T.M. Koelman, A. John F. Boere, Anke H. Maitland‐van der Zee and Nicole Janssen and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Environment International and European Respiratory Journal.

In The Last Decade

M Berger

10 papers receiving 628 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bronchoalveolar Lavage Findings in Cystic Fibrosis Patients with Stable, Clinically Mild Lung Disease Suggest Ongoing Infection and Inflammation

1994 430 citations Michael W. Konstan, Kathleen A. Hilliard et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Berger Netherlands	7	477	124	96	60	57	12	637
Nicole C. Shaw Australia	12	357 0.7×	151 1.2×	96 1.0×	101 1.7×	99 1.7×	24	598
Kevin Looi Australia	11	290 0.6×	140 1.1×	47 0.5×	93 1.6×	105 1.8×	26	465
Thomas Iosifidis Australia	11	296 0.6×	132 1.1×	53 0.6×	92 1.5×	112 2.0×	33	500
Elizabeth Kicic‐Starcevich Australia	10	252 0.5×	118 1.0×	44 0.5×	84 1.4×	99 1.7×	22	417
Sarah L. O’Beirne United States	12	249 0.5×	65 0.5×	103 1.1×	61 1.0×	52 0.9×	28	523
K. Cullen United States	8	372 0.8×	334 2.7×	40 0.4×	15 0.3×	29 0.5×	14	592
Janice Richman–Eisenstat Canada	11	426 0.9×	178 1.4×	107 1.1×	75 1.3×	109 1.9×	24	672
Patrycja Nejman‐Gryz Poland	14	249 0.5×	256 2.1×	84 0.9×	48 0.8×	128 2.2×	52	582
Sonja Bobic Belgium	9	185 0.4×	126 1.0×	100 1.0×	23 0.4×	96 1.7×	15	440
Keiko Kan‐o Japan	16	254 0.5×	185 1.5×	146 1.5×	119 2.0×	232 4.1×	42	685

Countries citing papers authored by M Berger

Since Specialization

Citations

This map shows the geographic impact of M Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Berger more than expected).

Fields of papers citing papers by M Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Berger. The network helps show where M Berger may publish in the future.

Co-authorship network of co-authors of M Berger

This figure shows the co-authorship network connecting the top 25 collaborators of M Berger. A scholar is included among the top collaborators of M Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Berger. M Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Zimmermann, Markus, Frank de Vocht, M Berger, et al.. (2024). Gibt es unterschiedliche Determinanten auf die Lebensqualität innerhalb junger und älterer Patient:innen unter Heim-NIV-Therapie: Auswertung der prospektiven monozentrischen CONIVCO-Studie. Pneumologie.

Janssen, Nicole, A. John F. Boere, M Berger, et al.. (2020). Effects of short-term exposures to ultrafine particles near an airport in healthy subjects. Environment International. 141. 105779–105779. 43 indexed citations

Bottiger, Brandi, et al.. (2018). Posterior Reversible Encephalopathy Syndrome After Lung Transplant: Clinical Characteristics and Outcomes. The Journal of Heart and Lung Transplantation. 37(4). S252–S253.

Berger, M, J. Daan de Boer, René Lutter, et al.. (2017). Pulmonary challenge with carbon nanoparticles induces a dose-dependent increase in circulating leukocytes in healthy males. BMC Pulmonary Medicine. 17(1). 121–121. 6 indexed citations

Berger, M, Patricia J. Kooyman, Michiel Makkee, et al.. (2016). How to achieve safe, high-quality clinical studies with non-Medicinal Investigational Products? A practical guideline by using intra-bronchial carbon nanoparticles as case study. Respiratory Research. 17(1). 102–102. 2 indexed citations

Boer, J. Daan de, M Berger, Christof J. Majoor, et al.. (2015). Activated protein C inhibits neutrophil migration in allergic asthma: a randomised trial. European Respiratory Journal. 46(6). 1636–1644. 14 indexed citations

Berger, M, J. Daan de Boer, Paul Bresser, et al.. (2014). Lipopolysaccharide amplifies eosinophilic inflammation after segmental challenge with house dust mite in asthmatics. Allergy. 70(3). 257–264. 13 indexed citations

Amelink, Marijke, Selma B. de Nijs, M Berger, et al.. (2012). Non‐atopic males with adult onset asthma are at risk of persistent airflow limitation. Clinical & Experimental Allergy. 42(5). 769–774. 24 indexed citations

Berger, M, M. Vermeulen, J.H.T.M. Koelman, Ivo N. van Schaik, & Y. B. W. E. M. Roos. (2012). The long-term follow-up of treatment with corticosteroid injections in patients with carpal tunnel syndrome. When are multiple injections indicated?. Journal of Hand Surgery (European Volume). 38(6). 634–639. 28 indexed citations

10.

Berger, M, Paul Bresser, Tom van der Poll, et al.. (2011). Local And Systemic Inflammatory Responses Following Low-Dose Bronchial Endotoxin Instillation In Mild Asthmatics. A2545–A2545. 2 indexed citations

11.

Konstan, Michael W., et al.. (1994). Bronchoalveolar Lavage Findings in Cystic Fibrosis Patients with Stable, Clinically Mild Lung Disease Suggest Ongoing Infection and Inflammation. American Journal of Respiratory and Critical Care Medicine. 150(2). 448–454. 430 indexed citations breakdown →

12.

Konstan, Michael W. & M Berger. (1993). Infection and inflammation of the lung in cystic fibrosis. 64. 219–276. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact